← Open Payments lookup

STANISLAV KRUGLIKOV: Open Payments

NPI 1316048986 · PENSACOLA, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$3,734 in 201 payments from 16 companies in 2025. Trend: 2023 $358 · 2024 $1,924 · 2025 $3,734

Food & beverage: $3,734
CompanyPaymentsAmount
Neurocrine BioSciences, Inc.28$909
E.R. Squibb & Sons, L.L.C.32$520
Alkermes, Inc.19$396
Teva Pharmaceuticals USA, Inc.25$381
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)23$361
ABBVIE INC.25$325
Lundbeck LLC12$212
Janssen Pharmaceuticals, Inc10$194
Otsuka America Pharmaceutical, Inc.13$154
Axsome Therapeutics, Inc.6$109

Products named: INGREZZA, COBENFY, ARISTADA, CAPLYTA, VRAYLAR, REXULTI, AUSTEDO XR, SPRAVATO.

Industry payments across FL — which companies pay providers there.